Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Finch Therapeutics Group Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Finch Therapeutics Group Inc market cap is $12.85M.
What is the 52-week high for Finch Therapeutics Group Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Finch Therapeutics Group Inc 52 week high is $16.10 as of April 11, 2026.
What is the 52-week low for Finch Therapeutics Group Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Finch Therapeutics Group Inc 52 week low is $2.00 as of April 11, 2026.
What is Finch Therapeutics Group Inc stock price today?
Finch Therapeutics Group Inc stock price today is $8.00.
What was Finch Therapeutics Group Inc stock price yesterday?
Finch Therapeutics Group Inc stock price yesterday was $8.00.
What is the 50-day moving average of Finch Therapeutics Group Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Finch Therapeutics Group Inc 50-day moving average is $11.93.